Koers Pandion Therapeutics, Inc.
Aandelen
PAND
US6983401067
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 56 | - |
Chief Tech/Sci/R&D Officer | - | 01-06-17 | |
John Sundy
CTO | Chief Tech/Sci/R&D Officer | 62 | 01-05-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,54% | 108 mld. | |
+9,68% | 104 mld. | |
+6,58% | 23,66 mld. | |
-12,37% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,36% | 18,2 mld. | |
-13,33% | 16,19 mld. | |
+4,13% | 13,72 mld. | |
+34,29% | 12,22 mld. |